China's unwavering commitment to fostering innovation and expanding opening up has not only propelled its domestic ...

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Medtronic (MDT – Research Report), with a price target ...

Medtronic (MDT) closed the latest trading day at $88.98, indicating a +0.85% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 0.33%.

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...

Three Intel board members will not stand for reelection at its 2025 annual meeting, the chipmaker said in a regulatory filing ...

Medtronic’s diverse portfolio faces financial growth concerns. Learn why MDT stock is a HOLD, offering stability but limited growth in the short term.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 12 Best Consistent Dividend Stocks to Buy. In this article, we are going to take a look at ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...